Heartflow (NASDAQ:HTFL) Trading Down 8.5% – Here’s Why

Heartflow, Inc. (NASDAQ:HTFL) shares traded down 8.5% on Monday . The stock traded as low as $29.28 and last traded at $29.50. 354,549 shares were traded during mid-day trading, a decline of 24% from the average session volume of 465,698 shares. The stock had previously closed at $32.25.

Analysts Set New Price Targets

HTFL has been the topic of a number of recent research reports. Morgan Stanley initiated coverage on shares of Heartflow in a research note on Tuesday, September 2nd. They set an “equal weight” rating and a $35.00 price target on the stock. Weiss Ratings restated a “sell (d)” rating on shares of Heartflow in a research report on Monday. Wall Street Zen upgraded Heartflow to a “hold” rating in a research report on Saturday, August 16th. Canaccord Genuity Group boosted their price objective on Heartflow from $39.00 to $40.00 and gave the stock a “buy” rating in a research note on Thursday, November 13th. Finally, JPMorgan Chase & Co. raised their price objective on Heartflow from $36.00 to $40.00 and gave the company an “overweight” rating in a research note on Thursday, November 13th. Four investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $38.60.

Heartflow Stock Performance

The business has a 50 day moving average price of $33.67.

Heartflow (NASDAQ:HTFL) last issued its quarterly earnings results on Friday, September 19th. The company reported ($1.46) earnings per share for the quarter, missing the consensus estimate of ($0.20) by ($1.26). The firm had revenue of $43.42 million during the quarter, compared to analysts’ expectations of $43.20 million.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the stock. Wellington Management Group LLP bought a new stake in Heartflow during the 3rd quarter valued at about $164,263,000. Baillie Gifford & Co. bought a new position in Heartflow in the 3rd quarter worth about $101,182,000. Schusterman Interests LLC purchased a new position in shares of Heartflow during the third quarter worth approximately $65,274,000. Vanguard Group Inc. bought a new stake in shares of Heartflow during the third quarter valued at approximately $48,871,000. Finally, Capital International Investors purchased a new stake in shares of Heartflow in the third quarter valued at approximately $43,671,000.

About Heartflow

We have pioneered the use of software and AI to deliver a more accurate and clinically effective non-invasive solution for diagnosing and managing coronary artery disease (“CAD”), a leading cause of death worldwide. As of March 31, 2025, our Heartflow Platform has been used to assess CAD in more than 400,000 patients, including 132,000 in 2024 alone.